Global Vitamin B12 Deficiency Treatment Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Vitamin B12 Deficiency Treatment Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Vitamin B12, is an important water-soluble vitamin. It mainly helps in nerve tissue health, brain function and red blood cells production. Also, vitamin helps in bone formation, mineralization, and growth. In large surveys in the United States and the United Kingdom, approx. 6% of those aged more than 60 years are Vitamin B12 deficient.
Vitamin B12 Deficiency Treatment report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Vitamin B12 Deficiency Treatment market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacy and Online Sales are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Vitamin B12 Deficiency Treatment industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Vitamin B12 Deficiency Treatment key companies include Watson Company, Merck, Daiichi Sankyo, Dr. Reddy’s Laboratories, Mylan, Pfizer, Teligent, Himalaya Herbal Healthcare and Dabur International, etc. Watson Company, Merck, Daiichi Sankyo are top 3 players and held % share in total in 2022.
Vitamin B12 Deficiency Treatment can be divided into Hydroxocobalamin and Cyanocobalamin, etc. Hydroxocobalamin is the mainstream product in the market, accounting for % share globally in 2022.
Vitamin B12 Deficiency Treatment is widely used in various fields, such as Hospital Pharmacy, Online Sales and Retail Pharmacy,, etc. Hospital Pharmacy provides greatest supports to the Vitamin B12 Deficiency Treatment industry development. In 2022, global % share of Vitamin B12 Deficiency Treatment went into Hospital Pharmacy filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Vitamin B12 Deficiency Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Watson Company
Merck
Daiichi Sankyo
Dr. Reddy’s Laboratories
Mylan
Pfizer
Teligent
Himalaya Herbal Healthcare
Dabur International
Segment by Type
Hydroxocobalamin
Cyanocobalamin
Hospital Pharmacy
Online Sales
Retail Pharmacy
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Vitamin B12 Deficiency Treatment market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Vitamin B12 Deficiency Treatment introduction, etc. Vitamin B12 Deficiency Treatment Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Vitamin B12 Deficiency Treatment market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Vitamin B12 Deficiency Treatment report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Vitamin B12 Deficiency Treatment market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacy and Online Sales are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Vitamin B12 Deficiency Treatment industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Vitamin B12 Deficiency Treatment key companies include Watson Company, Merck, Daiichi Sankyo, Dr. Reddy’s Laboratories, Mylan, Pfizer, Teligent, Himalaya Herbal Healthcare and Dabur International, etc. Watson Company, Merck, Daiichi Sankyo are top 3 players and held % share in total in 2022.
Vitamin B12 Deficiency Treatment can be divided into Hydroxocobalamin and Cyanocobalamin, etc. Hydroxocobalamin is the mainstream product in the market, accounting for % share globally in 2022.
Vitamin B12 Deficiency Treatment is widely used in various fields, such as Hospital Pharmacy, Online Sales and Retail Pharmacy,, etc. Hospital Pharmacy provides greatest supports to the Vitamin B12 Deficiency Treatment industry development. In 2022, global % share of Vitamin B12 Deficiency Treatment went into Hospital Pharmacy filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Vitamin B12 Deficiency Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Watson Company
Merck
Daiichi Sankyo
Dr. Reddy’s Laboratories
Mylan
Pfizer
Teligent
Himalaya Herbal Healthcare
Dabur International
Segment by Type
Hydroxocobalamin
Cyanocobalamin
Segment by Application
Hospital Pharmacy
Online Sales
Retail Pharmacy
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Vitamin B12 Deficiency Treatment market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Vitamin B12 Deficiency Treatment introduction, etc. Vitamin B12 Deficiency Treatment Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Vitamin B12 Deficiency Treatment market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.